BIOSPECIFICS TECHNOLOGIES CORP·4

Dec 13, 10:39 AM ET

BIOSPECIFICS TECHNOLOGIES CORP 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Dec 13, 2016

Insider Transaction Report

Form 4
Period: 2016-12-08
Wegman Thomas
DirectorPresident10% Owner
Transactions
  • Sale

    Common Stock, $.001 par value

    2016-12-08$49.54/sh15,000$743,112930,879 total
Footnotes (1)
  • [F1]The selling price of $49.5408 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.20 to $50.13. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES